The clinical trial treatment combined a powerful immune system activator with an immunotherapy agent and suggests it could be effective against advanced melanoma that has either not responded to or has progressed during therapy with the immunotherapy agent alone.

University of Iowa research indicates newly identified stem cells may hold key to regenerative therapies for lung disease.